Kari Eyer

Title: Kari Eyer - Innovator in Therapeutic Nanoparticles

Introduction

Kari Eyer is a notable inventor based in Sinking Spring, PA (US). She has made significant contributions to the field of therapeutic nanoparticles, particularly in the development of innovative solutions for disease treatment. Her work focuses on the incorporation of siRNA into calcium phosphate nanoparticles, which has the potential to revolutionize targeted therapies.

Latest Patents

Kari Eyer holds a patent for "Therapeutic calcium phosphate nanoparticle incorporating siRNA useful in treating disease." This invention involves the formation of stable, non-toxic calcium phosphate nanoparticles that incorporate one or more oligonucleotides, specifically siRNA nucleotides. The nanoparticles are designed to dissociate, leaving behind naturally occurring materials such as calcium and phosphate, along with the siRNA. This unique feature makes them particularly effective as carrier vehicles. The ability to incorporate multiple siRNA allows for the simultaneous blocking or knockdown of several targeted proteins, enhancing therapeutic efficacy.

Career Highlights

Throughout her career, Kari Eyer has demonstrated a commitment to advancing medical technology through her innovative research. Her work has garnered attention for its potential applications in treating various diseases, showcasing her expertise in the field of nanomedicine.

Collaborations

Kari collaborates with talented individuals such as Mylisa Parette and Danielle Asquino. Their combined efforts contribute to the advancement of research in therapeutic nanoparticles and their applications.

Conclusion

Kari Eyer's contributions to the field of therapeutic nanoparticles highlight her innovative spirit and dedication to improving healthcare solutions. Her patent for calcium phosphate nanoparticles incorporating siRNA represents a significant advancement in targeted therapy, showcasing the potential for future developments in this area.